tolvaptan

Italy

Drugs containing this active substance

  • JINARC

    It is used to treat a condition called 'autosomal dominant polycystic kidney disease' (ADPKD) in adults with stage 1 to 4 chronic kidney disease who show rapid disease progression. The drug helps slow the development of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan -

    ATC: C03XA01

    Manufacturer: OTSUKA PHARMACEUTICAL NETHERLANDS BV

  • It is used to treat patients with low sodium concentrations in the blood caused by syndrome of inappropriate antidiuretic hormone secretion (SIADH), a condition in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan -

    ATC: C03XA01

    Manufacturer: OTSUKA PHARMACEUTICAL NETHERLANDS BV

  • It is used to treat patients with low sodium concentrations in the blood caused by syndrome of inappropriate antidiuretic hormone secretion (SIADH), a condition in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan -

    ATC: C03XA01

    Manufacturer: ACCORD HEALTHCARE, S.L.U.